Sanne de Jongh
MSc – Gilde Healthcare

Sanne de Jongh is Investment Manager at Gilde Healthcare, where she focuses on the firms’ investment activities in the biopharmaceutical sector. She currently represents Gilde on the boards of ADCendo ApS and Calypso Biotech B.V.

Prior to joining Gilde in 2017, Sanne was with Anterra Capital, a global VC fund backed by Fidelity and Rabobank focused on food and agriculture innovations. Here she worked on several biotech investments, such as Caribou Bioscienes Inc., Enko Chem Inc. and Agrimetis LLC. She began her career at MS Ventures, the biopharma fund of Merck KGaA, where she reviewed early stage strategic investments and supported portfolio companies.

Sanne holds a M.Sc. (cum laude) in Biochemistry from Delft University of Technology and Leiden University, with a specialization in Neurology from the LUMC, the Netherlands. She is a Dutch national.